Literature DB >> 481551

Enhancement of memory by physostigmine.

K L Davis, R C Mohs, J R Tinklenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 481551     DOI： 10.1056/NEJM197910253011722

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

Review 1.  Alzheimer's therapeutics: translation of preclinical science to clinical drug development.

Authors:  Alena V Savonenko; Tatiana Melnikova; Andrew Hiatt; Tong Li; Paul F Worley; Juan C Troncoso; Phil C Wong; Don L Price
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

2.  Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert.

Authors:  T G Aigner; S J Mitchell; J P Aggleton; M R DeLong; R G Struble; D L Price; G L Wenk; M Mishkin
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 3.  Physostigmine for Alzheimer's disease.

Authors:  F Coelho; J Birks
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 4.  Cholinesterase inhibitors stabilize Alzheimer disease.

Authors:  E Giacobini
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

5.  Quantitative whole-body autoradiographic determination of tacrine tissue distribution in rats following intravenous or oral dose.

Authors:  W McNally; M Roth; R Young; H Bockbrader; T Chang
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

Review 6.  Diagnosis and treatment of dementia in the aged.

Authors:  G W Small; E H Liston; L F Jarvik
Journal:  West J Med       Date:  1981-12

Review 7.  Hormesis and medicine.

Authors:  Edward J Calabrese
Journal:  Br J Clin Pharmacol       Date:  2008-06-28       Impact factor: 4.335

Review 8.  Psychobiological evidence for the distinction between episodic and semantic memory.

Authors:  M D Horner
Journal:  Neuropsychol Rev       Date:  1990-12       Impact factor: 7.444

Review 9.  Pharmaceutical treatment for cognitive deficits in Alzheimer's disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps.

Authors:  Raymond T Bartus; Reginald L Dean
Journal:  Psychopharmacology (Berl)       Date:  2008-11-15       Impact factor: 4.530

10.  Memory-enhancing activity of palmatine in mice using elevated plus maze and morris water maze.

Authors:  Dinesh Dhingra; Varun Kumar
Journal:  Adv Pharmacol Sci       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.